BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 12818830)

  • 1. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
    Wen YL; Kudo M; Zheng RQ; Minami Y; Chung H; Suetomi Y; Onda H; Kitano M; Kawasaki T; Maekawa K
    AJR Am J Roentgenol; 2003 Jul; 181(1):57-63. PubMed ID: 12818830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.
    Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Chung H; Kawasaki T; Maekawa K
    Radiology; 2001 Dec; 221(3):721-30. PubMed ID: 11719668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
    Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
    AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography.
    Minami Y; Kudo M; Kawasaki T; Kitano M; Chung H; Maekawa K; Shiozaki H
    AJR Am J Roentgenol; 2003 Mar; 180(3):703-8. PubMed ID: 12591679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.
    Wen YL; Kudo M; Zheng RQ; Ding H; Zhou P; Minami Y; Chung H; Kitano M; Kawasaki T; Maekawa K
    AJR Am J Roentgenol; 2004 Apr; 182(4):1019-26. PubMed ID: 15039180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
    Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
    AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of intratumoral vascularity in small hepatocellular carcinoma by coded phase inversion harmonics.
    Wen YL; Zhou P; Kudo M
    Intervirology; 2004; 47(3-5):169-78. PubMed ID: 15383726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-dimensional ultrasonography for therapeutic radiofrequency ablation for hepatocellular carcinoma.
    Hotta N; Maeno T; Ayada M; Sato K; Ishikawa T; Okumura A; Matsumoto E; Fukuzawa Y; Kakumu S
    Hepatogastroenterology; 2006; 53(70):521-5. PubMed ID: 16995453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
    Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of contrast-enhanced ultrasonography with dynamic flow imaging to evaluate therapeutic effects for hepatocellular carcinoma.
    Hotta N; Tagaya T; Maeno T; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
    Hepatogastroenterology; 2003; 50(54):1867-71. PubMed ID: 14696421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma.
    Numata K; Isozaki T; Ozawa Y; Sakaguchi T; Kiba T; Kubota T; Ito A; Sugimori K; Shirato K; Morimoto M; Tanaka K
    AJR Am J Roentgenol; 2003 Jan; 180(1):143-9. PubMed ID: 12490493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma.
    Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Maekawa K
    AJR Am J Roentgenol; 2001 Mar; 176(3):661-6. PubMed ID: 11222201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation.
    Minami Y; Kitai S; Kudo M
    Eur J Radiol; 2012 Mar; 81(3):e277-80. PubMed ID: 21392916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography.
    Numata K; Morimoto M; Ogura T; Sugimori K; Takebayashi S; Okada M; Tanaka K
    J Ultrasound Med; 2008 Mar; 27(3):395-406. PubMed ID: 18314518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent.
    Choi D; Lim HK; Lee WJ; Kim SH; Kim YH; Kim SH; Lim JH
    J Ultrasound Med; 2003 Nov; 22(11):1163-72. PubMed ID: 14620886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of 1.5 harmonic imaging ultrasonography with Levovist in the diagnosis of focal hepatic tumors.
    Yamamoto K; Shiraki K; Nakanishi S; Fuke H; Hashimoto A; Shimizu A; Nakano T
    Int J Oncol; 2005 Oct; 27(4):989-95. PubMed ID: 16142315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced dynamic flow imaging with contrast-enhanced ultrasonography for the evaluation of tumor vascularity in liver tumors.
    Hotta N; Tagaya T; Maeno T; Ayada M; Sato K; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
    Clin Imaging; 2005; 29(1):34-41. PubMed ID: 15859016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography.
    Minami Y; Kudo M; Kawasaki T; Chung H; Ogawa C; Shiozaki H
    AJR Am J Roentgenol; 2004 Jul; 183(1):153-6. PubMed ID: 15208130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma?
    Ricci P; Cantisani V; Drudi F; Pagliara E; Bezzi M; Meloni F; Calliada F; Erturk SM; D'Andrea V; D'Ambrosio U; Passariello R
    Ultraschall Med; 2009 Jun; 30(3):252-8. PubMed ID: 19280552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.